These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

492 related items for PubMed ID: 8476211

  • 1. NK cells from mammary tumor bearing mice do not exert natural killer activity but function as antibody dependent cellular cytotoxicity effectors.
    Rivera LM, Lopez DM.
    Anticancer Res; 1993; 13(1):177-84. PubMed ID: 8476211
    [Abstract] [Full Text] [Related]

  • 2. Soluble and membrane-bound TNF-alpha are involved in the cytotoxic activity of B cells from tumor-bearing mice against tumor targets.
    Lopez-Cepero M, Garcia-Sanz JA, Herbert L, Riley R, Handel ME, Podack ER, Lopez DM.
    J Immunol; 1994 Apr 01; 152(7):3333-41. PubMed ID: 8144919
    [Abstract] [Full Text] [Related]

  • 3. Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas.
    Fu Y, Paul RD, Wang Y, Lopez DM.
    J Immunol; 1989 Dec 15; 143(12):4300-7. PubMed ID: 2592775
    [Abstract] [Full Text] [Related]

  • 4. Natural killer cells in mouse lung: surface phenotype, target preference, and response to local influenza virus infection.
    Stein-Streilein J, Bennett M, Mann D, Kumar V.
    J Immunol; 1983 Dec 15; 131(6):2699-704. PubMed ID: 6644021
    [Abstract] [Full Text] [Related]

  • 5. Modulation of murine natural killer cells by a granulocytosis-inducing tumor.
    Pollack SB, Lee MY, Cohen E, Lottsfeldt JL, Rosse C.
    Cancer Res; 1989 Jan 01; 49(1):174-8. PubMed ID: 2908844
    [Abstract] [Full Text] [Related]

  • 6. Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicity.
    Katz JD, Mitsuyasu R, Gottlieb MS, Lebow LT, Bonavida B.
    J Immunol; 1987 Jul 01; 139(1):55-60. PubMed ID: 3584988
    [Abstract] [Full Text] [Related]

  • 7. Stimulation of natural killer cell numbers but not function in leukemic infant mice: a system primed in infancy allows survival in adulthood.
    Dussault I, Miller SC.
    Nat Immun; 1993 Jul 01; 12(2):66-78. PubMed ID: 8318817
    [Abstract] [Full Text] [Related]

  • 8. Triggering of the cytotoxic activity of murine natural killer and lymphokine-activated killer cells through the NK2.1 antigen.
    Morelli L, Lemieux S.
    J Immunol; 1993 Dec 15; 151(12):6783-93. PubMed ID: 8258690
    [Abstract] [Full Text] [Related]

  • 9. Identity of effector cells participating in the reverse antibody-dependent cell-mediated cytotoxicity.
    Saxena RK, Saxena QB, Adler WH.
    Immunology; 1982 Jun 15; 46(2):459-64. PubMed ID: 7084998
    [Abstract] [Full Text] [Related]

  • 10. Antibody-dependent natural killer cell-mediated cytotoxicity engendered by a kinase-inactive human HER2 adenovirus-based vaccination mediates resistance to breast tumors.
    Triulzi C, Vertuani S, Curcio C, Antognoli A, Seibt J, Akusjärvi G, Wei WZ, Cavallo F, Kiessling R.
    Cancer Res; 2010 Oct 01; 70(19):7431-41. PubMed ID: 20823150
    [Abstract] [Full Text] [Related]

  • 11. Characteristics of murine non-specific killer cells induced in vivo by recombinant human interleukin-2.
    Hinuma S, Naruo K, Shiho O, Tsukamoto K.
    Immunology; 1986 Oct 01; 59(2):251-9. PubMed ID: 3490435
    [Abstract] [Full Text] [Related]

  • 12. Natural killer (NK) cells as a responder to interleukin 2 (IL 2). I. Proliferative response and establishment of cloned cells.
    Suzuki R, Handa K, Itoh K, Kumagai K.
    J Immunol; 1983 Feb 01; 130(2):981-7. PubMed ID: 6600260
    [Abstract] [Full Text] [Related]

  • 13. Origin and differentiation of natural killer cells. II. Functional and morphologic studies of purified NK-1.1+ cells.
    Hackett J, Tutt M, Lipscomb M, Bennett M, Koo G, Kumar V.
    J Immunol; 1986 Apr 15; 136(8):3124-31. PubMed ID: 3958492
    [Abstract] [Full Text] [Related]

  • 14. Emergence of a B lymphocyte population with ADCC effector function in mammary tumor bearing mice.
    Padmanabhan RR, Paul RD, Watson GA, Lopez DM.
    J Leukoc Biol; 1988 Jun 15; 43(6):509-19. PubMed ID: 3259973
    [Abstract] [Full Text] [Related]

  • 15. Immunologic control of a retrovirus-associated murine adenocarcinoma. VIII. Corynebacterium parvum-activated natural killer cells as potent antibody-dependent cell-mediated cytotoxicity effectors.
    Weinhold KJ, Bolognesi DP, Matthews TJ.
    J Natl Cancer Inst; 1985 Oct 15; 75(4):717-24. PubMed ID: 3862904
    [Abstract] [Full Text] [Related]

  • 16. Correlation between natural and antibody-dependent cell-mediated cytotoxicity against tumor targets in the mouse. II. Characterization of the effector cells.
    Santoni A, Herberman RB, Holden HT.
    J Natl Cancer Inst; 1979 Oct 15; 63(4):995-1003. PubMed ID: 384012
    [Abstract] [Full Text] [Related]

  • 17. Expression of asialo GM1 and other antigens and glycolipids on natural killer cells and spleen leukocytes in virus-infected mice.
    Yang H, Yogeeswaran G, Bukowski JF, Welsh RM.
    Nat Immun Cell Growth Regul; 1985 Oct 15; 4(1):21-39. PubMed ID: 3875791
    [Abstract] [Full Text] [Related]

  • 18. Splenocyte natural killer cell activity and metastatic potential are inversely dependent on estrous stage.
    Gruber SA, Hoffman RA, Sothern RB, Lakatua D, Carlson A, Simmons RL, Hrushesky WJ.
    Surgery; 1988 Aug 15; 104(2):398-403. PubMed ID: 3261050
    [Abstract] [Full Text] [Related]

  • 19. Differential modulation of LAK and ADCC functions of natural killer cells from AK-5 tumor-bearing rats by IL-2, IL-12 and IFN-gamma.
    Muralikrishna K, Varalakshmi C, Khar A.
    Cytokines Cell Mol Ther; 1997 Mar 15; 3(1):51-8. PubMed ID: 9287244
    [Abstract] [Full Text] [Related]

  • 20. Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density.
    Niwa R, Sakurada M, Kobayashi Y, Uehara A, Matsushima K, Ueda R, Nakamura K, Shitara K.
    Clin Cancer Res; 2005 Mar 15; 11(6):2327-36. PubMed ID: 15788684
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.